Related Experiment Video
Updated: Jun 26, 2026

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
Modulation of aromatase activity by diet polyphenolic compounds
Rosário Monteiro1, Isabel Azevedo, Conceição Calhau
1Department of Biochemistry (U38-FCT), Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal. rosariom@med.up.pt
Polyphenols, found in beverages like red wine and green tea, can inhibit estrogen synthesis by affecting aromatase activity. This discovery may aid in preventing and treating estrogen-dependent disorders.
Area of Science:
- Biochemistry
- Endocrinology
- Nutritional Science
Background:
- Estrogens play crucial roles in reproduction, fat distribution, bone health, and the development of estrogen-dependent cancers.
- Understanding factors that modulate estrogen synthesis is vital for managing related health conditions.
Purpose of the Study:
- To investigate the impact of various polyphenols and polyphenol-rich beverages on estrogen synthesis.
- To determine the effect of these compounds on aromatase activity, a key enzyme in estrogen production.
Main Methods:
- Utilized JAR cells (choriocarcinoma cell line) to test polyphenol effects on aromatase activity.
- Employed the tritiated water release assay to quantify enzyme activity.
- Assessed aromatase gene and protein expression using RT-PCR and Western blotting.
Main Results:
- Several tested polyphenols, notably chrysin, demonstrated significant inhibition of estrogen production.
- Red wine, alcohol-free red wine, green tea, and black tea markedly reduced aromatase activity at 200 microL/mL.
- No significant changes in aromatase expression levels were observed after 24-hour treatment with the studied flavonoids.
Conclusions:
- Polyphenols possess the ability to modulate aromatase activity, thereby influencing estrogen synthesis.
- These findings provide insights into the biological actions of polyphenols and their potential therapeutic applications in estrogen-dependent disorders.
Related Concept Videos
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Factors Affecting Drug Biotransformation: Biological
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Cancer Prevention
Some...
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Pharmacogenetics of Drug Metabolism: Overview
